Eurofins Scientific SE (Eurofins Scientific SE) Total Liabilities : $6,272 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Eurofins Scientific SE Total Liabilities?

Eurofins Scientific SE's Total Liabilities for the quarter that ended in Dec. 2023 was $6,272 Mil.

Eurofins Scientific SE's quarterly Total Liabilities increased from Dec. 2022 ($5,542.90 Mil) to Jun. 2023 ($5,688.19 Mil) and increased from Jun. 2023 ($5,688.19 Mil) to Dec. 2023 ($6,271.76 Mil).

Eurofins Scientific SE's annual Total Liabilities increased from Dec. 2021 ($5,260.11 Mil) to Dec. 2022 ($5,542.90 Mil) and increased from Dec. 2022 ($5,542.90 Mil) to Dec. 2023 ($6,271.76 Mil).

Eurofins Scientific SE Total Liabilities Historical Data

The historical data trend for Eurofins Scientific SE's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins Scientific SE Total Liabilities Chart

Eurofins Scientific SE Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

5,472.22

5,911.31

5,260.11

5,542.90

6,271.76

Eurofins Scientific SE Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial															5,260.11	5,807.08	5,542.90	5,688.19	6,271.76

Eurofins Scientific SE Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Eurofins Scientific SE's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2313.74	+	(3626.499	+	259.325
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	72.192)
	=	6,272

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	11874.155	-	5602.399
	=	6,272

Eurofins Scientific SE's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2313.74	+	(3626.499	+	259.325
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	72.192)
	=	6,272

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	11874.155	-	5602.399
	=	6,272

Eurofins Scientific SE Total Liabilities Related Terms

Thank you for viewing the detailed overview of Eurofins Scientific SE's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Eurofins Scientific SE (Eurofins Scientific SE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins Scientific SE (OTCPK:ERFSF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

ERFp:UK 0MV5:UK ERF:France ESF0:Germany

Address

23 Val Fleuri, Luxembourg, LUX, L-1526

Website

https://www.eurofins.com

Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its main business activities are food and environmental testing, biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.